Surrogate end points in clinical trials: are we being misled?

Ann Intern Med. 1996 Oct 1;125(7):605-13. doi: 10.7326/0003-4819-125-7-199610010-00011.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Clinical Trials, Phase II as Topic / methods
  • Clinical Trials, Phase II as Topic / standards
  • Clinical Trials, Phase III as Topic / methods*
  • Clinical Trials, Phase III as Topic / standards*
  • Humans